top of page

OSL

Oncosil Medical Ltd

Life Sciences Tools and Services

·

Healthcare

3

comments

1

fund manager

past 90 days

About Oncosil Medical Ltd

OncoSil Medical Ltd. is an Australian-based medical technology company founded in 2005, headquartered in Macquarie Park. The company specializes in the development and commercialization of innovative radiation therapy treatments, focusing primarily on pancreatic cancer applications. OncoSil Medical aims to provide safer, more effective neurology and oncology solutions. As a medical device firm, it concentrates on advancing novel therapeutic technologies to address unmet clinical needs in cancer treatment.

Commentary Volume

3

Comments

1

Fund managers

0

Past 90 days

SOURCE

ACTION

COMMENT PREVIEW

FUND MANAGER

DATE

Loading...

Source: Ipsum Capital Q4 Quarterly Letter  ·  Published 14 March 2025

Loading...

.

​Loading...

Loading...

Loading...

Loading...

Loading...

Source: Ipsum Capital Q4 Quarterly Letter  ·  Published 14 March 2025

Report a problem

Loading...

.

Loading...

Loading...

Loading...

Loading...

14 Mar 2025

ic

Ipsum Capital

"Lorem ipsum dolor sit amet...

Q4 Letter

14 Mar 2025

ic

Dolor Investments

"Lorem ipsum dolor sit amet...

Q4 Letter

🔒 21 more comments from 10 sources

Unlock full access

§ Important Notice

The entries below are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.

Commentary

Sector

Healthcare

Market cap

$16M

Fund managers

1 manager

First covered

30 Sept 2024

Last updated

31 May 2025

Company Details

Related Themes

ic

Ipsum Capital

6 comments

ic

Amet Funds

4 comments

ic

Dolor

3 comments

Top Investors Covering MIN

§ Reminder

The entries above are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.

Frequently asked questions about Oncosil Medical Ltd (ASX:OSL)

Frequently asked questions

Who is investing in Oncosil Medical Ltd (ASX:OSL)?

Fund managers including Pengana Capital Group have invested in Oncosil Medical Ltd (ASX:OSL).

What is the short interest in Oncosil Medical Ltd (ASX:OSL)?

According to ASIC filings, there is negligible or no short interest in Oncosil Medical Ltd (ASX:OSL).

What does Oncosil Medical Ltd (ASX:OSL) do?

OncoSil Medical Ltd. is an Australian-based medical technology company founded in 2005, headquartered in Macquarie Park. The company specializes in the development and commercialization of innovative radiation therapy treatments, focusing primarily on pancreatic cancer applications. OncoSil Medical aims to provide safer, more effective neurology and oncology solutions. As a medical device firm, it concentrates on advancing novel therapeutic technologies to address unmet clinical needs in cancer treatment.

bottom of page